Is AKTS options pricing rich or cheap right now?

As of Aug 28, 2026, Aktis Oncology, Inc. (AKTS) ATM IV is 100.1% against 20-day realized volatility of 47.0%. IV rank is 56.1%. AKTS options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 53.1 vol points.

What is the AKTS variance risk premium?

The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. AKTS is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.

What does AKTS IV rank mean for strategy selection?

IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. AKTS's current rank of 56.1% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.

Aktis Oncology, Inc. (AKTS) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Aktis Oncology, Inc. (AKTS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.38B, listed on NASDAQ, employing roughly 79 people, carrying a beta of 0.45 to the broader market. Aktis Oncology, Inc. Led by Matthew Roden, public since 2026-01-09.

Snapshot as of Aug 28, 2026.

Spot Price: $25.84
ATM IV: 100.1%
HV 20-Day: 47.0%
HV 60-Day: 1482.9%
IV Rank: 56.1%
IV Percentile: 88.5%

As of Aug 28, 2026, Aktis Oncology, Inc. (AKTS) ATM implied volatility is 100.1%. 20-day realized volatility is 47.0%, producing an IV-HV spread of +53.1 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 56.1%.

How AKTS iv/hv history Data Feeds Strategy Selection

Strategy selection on Aktis Oncology, Inc. options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 100.1% and dealer gamma exposure is negative, so dealer hedging amplifies directional moves. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the AKTS IV vs HV chart

The dual-line chart above tracks ATM implied volatility (forward-looking, what the chain is pricing) against 20-day realized historical volatility (backward-looking, what actually happened). ATM IV currently prints at 100.1%, 56.1% IV rank, against 47.0% realized over the trailing 20 trading days. Implied is pricing above realized by 53.1 vol points, the typical variance-risk-premium positive state in which premium sellers earn the gap. Persistent IV-above-HV is the variance-risk-premium-positive state typical of equity markets; persistent IV-below-HV is rare and usually marks underpriced vol that often expands.

AKTS IV/HV regimes and trade selection

AKTS IV rank at 56.1% sits mid-range - no structural edge from rank alone. Strategy choice should follow event calendar and the dealer-positioning read.

Using AKTS vol history alongside the term structure

The IV/HV gap on this page captures the level of premium; the term-structure slope on the volatility page captures its shape across expirations. Contango (positive slope 0.135) is the resting state - longer-dated IV trades above near-dated IV because long-dated cycles include uncertain macro states. Pair the rank read with the slope read with the event calendar to choose the right tenor for the structure.

AKTS IV/HV signal in volatility-cycle context

Equity-vol cycles tend to compress and expand on multi-month timeframes: a typical sequence runs low-IV-rank consolidation (months of flat tape, decaying premium) into a vol-expansion catalyst (earnings miss, macro shock, regime change) into elevated-IV-rank stress (premiums fat, dispersion high) back to mean-reverting compression. AKTS's 56.1% IV rank places the ticker in the mid-range of its 1-year window - no strong cycle-position signal. The ratio of HV-20 (47.0%) to HV-60 (1482.9%) gives a second cycle indicator: when 20-day exceeds 60-day, recent realization is running hotter than the trailing-quarter average - typically a sign that recent days have already started expanding vol regardless of where IV rank prints. Use the time series above to spot inflection points: meaningful IV/HV gap closures and openings tend to precede regime shifts by a few sessions.

Learn how implied vs realized volatility is reported and how to read the data →

Daily ATM implied volatility and 20-day realized (historical) volatility for AKTS over the last ~33 trading days. The IV-HV gap measures the variance risk premium - when IV trades persistently above realized HV, premium-sellers earn the spread; when IV dips below HV, vol is structurally underpriced.

Daily values from end-of-day option_ticker_snapshots. Series sparse on illiquid tickers reflects gaps in the upstream end-of-day options data feed.

Most recent 15 trading days (descending). Older history appears in the chart above.

Date	ATM IV	HV 20d	HV 60d	IV Rank
Aug 28, 2026	100.1%	47.0%	1482.9%	56.1%
Aug 27, 2026	94.5%	49.4%	1482.8%	52.3%
Aug 26, 2026	111.9%	49.4%	1482.8%	64.1%
Aug 25, 2026	86.1%	49.4%	1483.3%	46.6%
Aug 24, 2026	98.4%	54.5%	1483.4%	54.9%
Aug 21, 2026	125.9%	50.4%	1483.5%	73.6%
Aug 20, 2026	107.7%	50.3%	1483.5%	61.2%
Aug 19, 2026	109.7%	47.6%	1483.7%	62.6%
Aug 18, 2026	118.8%	48.9%	1483.8%	68.8%
Aug 17, 2026	106.4%	54.2%	1483.8%	60.4%
Aug 14, 2026	110.3%	59.7%	1484.3%	63.0%
Aug 13, 2026	116.0%	57.7%	1484.3%	66.9%
Aug 12, 2026	115.4%	57.7%	1484.2%	66.5%
Aug 11, 2026	144.2%	2540.4%	1484.0%	86.0%
Aug 10, 2026	160.9%	2540.4%	1484.0%	97.4%

Frequently asked AKTS iv/hv history questions

Is AKTS options pricing rich or cheap right now?: As of Aug 28, 2026, Aktis Oncology, Inc. (AKTS) ATM IV is 100.1% against 20-day realized volatility of 47.0%. IV rank is 56.1%. AKTS options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 53.1 vol points.
What is the AKTS variance risk premium?: The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. AKTS is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
What does AKTS IV rank mean for strategy selection?: IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. AKTS's current rank of 56.1% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.